{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:17:33Z","timestamp":1790900253320,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81XWH-07-1-0663"],"award-info":[{"award-number":["W81XWH-07-1-0663"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81XWH-11-1-0549-BC100597P1"],"award-info":[{"award-number":["W81XWH-11-1-0549-BC100597P1"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA 58207"],"award-info":[{"award-number":["P50 CA 58207"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10549-016-4036-0","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T15:52:14Z","timestamp":1477497134000},"page":"17-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast"],"prefix":"10.1007","volume":"161","author":[{"given":"Michael J.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Baehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"O\u2019Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekene","family":"Ojukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Booyeon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickram","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Endicott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelos","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe W.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"issue":"4","key":"4036_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.5858\/arpa.2012-0078-RA","volume":"137","author":"KP Siziopikou","year":"2013","unstructured":"Siziopikou KP (2013) Ductal carcinoma in situ of the breast: current concepts and future directions. Arch Pathol Lab Med 137(4):462\u2013466. doi:\n                    10.5858\/arpa.2012-0078-RA","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"4036_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12253-008-9054-8","volume":"14","author":"S Bianchi","year":"2008","unstructured":"Bianchi S, Vezzosi V (2008) Microinvasive carcinoma of the breast. Pathol Oncol Res 14(2):105\u2013111. doi:\n                    10.1007\/s12253-008-9054-8","journal-title":"Pathol Oncol Res"},{"issue":"6","key":"4036_CR3","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I","volume":"67","author":"D Rosner","year":"1991","unstructured":"Rosner D, Lane WW, Penetrante R (1991) Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 67(6):1498\u20131503","journal-title":"Cancer"},{"issue":"5","key":"4036_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/0360-3016(92)90900-3","volume":"23","author":"LJ Solin","year":"1992","unstructured":"Solin LJ, Fowble BL, Yeh IT, Kowalyshyn MJ, Schultz DJ, Weiss MC, Goodman RL (1992) Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23(5):961\u2013968","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"4036_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamaoncol.2015.2607","volume":"1","author":"L Esserman","year":"2015","unstructured":"Esserman L, Yau C (2015) Rethinking the standard for ductal carcinoma in situ treatment. JAMA Oncol 1(7):881\u2013883. doi:\n                    10.1001\/jamaoncol.2015.2607","journal-title":"JAMA Oncol"},{"issue":"7","key":"4036_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888\u2013896. doi:\n                    10.1001\/jamaoncol.2015.2510","journal-title":"JAMA Oncol"},{"issue":"21","key":"4036_CR7","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"N Bijker","year":"2006","unstructured":"Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853\u2014a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24(21):3381\u20133387. doi:\n                    10.1200\/JCO.2006.06.1366","journal-title":"J Clin Oncol"},{"issue":"8","key":"4036_CR8","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1200\/JCO.2001.19.8.2263","volume":"19","author":"N Bijker","year":"2001","unstructured":"Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascarel I, van de Vijver MJ (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19(8):2263\u20132271","journal-title":"J Clin Oncol"},{"issue":"2","key":"4036_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16(2):441\u2013452","journal-title":"J Clin Oncol"},{"issue":"4","key":"4036_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0093-7754(01)90133-2","volume":"28","author":"B Fisher","year":"2001","unstructured":"Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28(4):400\u2013418","journal-title":"Semin Oncol"},{"issue":"8","key":"4036_CR11","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1200\/JCO.2007.12.7969","volume":"26","author":"L Holmberg","year":"2008","unstructured":"Holmberg L, Garmo H, Granstrand B, Ringberg A, Arnesson LG, Sandelin K, Karlsson P, Anderson H, Emdin S (2008) Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26(8):1247\u20131252. doi:\n                    10.1200\/JCO.2007.12.7969","journal-title":"J Clin Oncol"},{"issue":"9378","key":"4036_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0140-6736(03)13859-7","volume":"362","author":"J Houghton","year":"2003","unstructured":"Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362(9378):95\u2013102","journal-title":"Lancet"},{"issue":"28","key":"4036_CR13","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1200\/JCO.2005.04.5518","volume":"24","author":"LJ Esserman","year":"2006","unstructured":"Esserman LJ, Kumar AS, Herrera AF, Leung J, Au A, Chen YY, Moore DH, Chen DF, Hellawell J, Wolverton D, Hwang ES, Hylton NM (2006) Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol 24(28):4603\u20134610. doi:\n                    10.1200\/JCO.2005.04.5518","journal-title":"J Clin Oncol"},{"issue":"1","key":"4036_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1245\/s10434-010-1214-x","volume":"18","author":"ES Wai","year":"2011","unstructured":"Wai ES, Lesperance ML, Alexander CS, Truong PT, Moccia P, Culp M, Lindquist J, Olivotto IA (2011) Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone. Ann Surg Oncol 18(1):119\u2013124. doi:\n                    10.1245\/s10434-010-1214-x","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"4036_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/archsurg.2010.243","volume":"145","author":"ED Kurniawan","year":"2010","unstructured":"Kurniawan ED, Rose A, Mou A, Buchanan M, Collins JP, Wong MH, Miller JA, Mann GB (2010) Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Arch Surg 145(11):1098\u20131104. doi:\n                    10.1001\/archsurg.2010.243","journal-title":"Arch Surg"},{"issue":"4","key":"4036_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9610(03)00265-4","volume":"186","author":"MJ Silverstein","year":"2003","unstructured":"Silverstein MJ (2003) The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 186(4):337\u2013343","journal-title":"Am J Surg"},{"issue":"2","key":"4036_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/tbj.12368","volume":"21","author":"MJ Silverstein","year":"2015","unstructured":"Silverstein MJ, Lagios MD (2015) Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California\/Van Nuys (USC\/VNPI) prognostic index. Breast J 21(2):127\u2013132. doi:\n                    10.1111\/tbj.12368","journal-title":"Breast J"},{"issue":"9","key":"4036_CR18","doi-asserted-by":"publisher","first-page":"e985930","DOI":"10.4161\/2162402X.2014.985930","volume":"4","author":"S Adams","year":"2015","unstructured":"Adams S, Goldstein LJ, Sparano JA, Demaria S, Badve SS (2015) Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC). Oncoimmunology 4(9):e985930. doi:\n                    10.4161\/2162402X.2014.985930","journal-title":"Oncoimmunology"},{"issue":"3","key":"4036_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10549-010-1154-y","volume":"128","author":"MJ Campbell","year":"2011","unstructured":"Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, Olopade OI, Esserman LJ (2011) Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat 128(3):703\u2013711. doi:\n                    10.1007\/s10549-010-1154-y","journal-title":"Breast Cancer Res Treat"},{"key":"4036_CR20","doi-asserted-by":"publisher","first-page":"785317","DOI":"10.1155\/2013\/785317","volume":"2013","author":"L de la Cruz-Merino","year":"2013","unstructured":"de la Cruz-Merino L, Barco-Sanchez A, Henao Carrasco F, Nogales Fernandez E, Vallejo Benitez A, Brugal Molina J, Martinez Peinado A, Grueso Lopez A, Ruiz Borrego M, Manuel Codes, de Villena M, Sanchez-Margalet V, Nieto-Garcia A, Alba Conejo E, Casares Lagar N, Ibanez Martinez J (2013) New insights into the role of the immune microenvironment in breast carcinoma. Clin Dev Immunol 2013:785317. doi:\n                    10.1155\/2013\/785317","journal-title":"Clin Dev Immunol"},{"issue":"7","key":"4036_CR21","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/JCI67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G, Veys I, Haibe-Kains B, Singhal SK, Michiels S, Rothe F, Salgado R, Duvillier H, Ignatiadis M, Desmedt C, Bron D, Larsimont D, Piccart M, Sotiriou C, Willard-Gallo K (2013) CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Investig 123(7):2873\u20132892. doi:\n                    10.1172\/JCI67428","journal-title":"J Clin Investig"},{"issue":"3","key":"4036_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10549-014-3185-2","volume":"148","author":"EM Ibrahim","year":"2014","unstructured":"Ibrahim EM, Al-Foheidi ME, Al-Mansour MM, Kazkaz GA (2014) The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis. Breast Cancer Res Treat 148(3):467\u2013476. doi:\n                    10.1007\/s10549-014-3185-2","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4036_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1186\/s12885-015-1742-7","volume":"15","author":"D Jiang","year":"2015","unstructured":"Jiang D, Gao Z, Cai Z, Wang M, He J (2015) Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis. BMC Cancer 15(1):727. doi:\n                    10.1186\/s12885-015-1742-7","journal-title":"BMC Cancer"},{"issue":"5","key":"4036_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/jclinpath-2015-203089","volume":"69","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Park IA, Song IH, Shin SJ, Kim JY, Yu JH, Gong G (2015) Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer. J Clin Pathol 69(5):422\u2013430. doi:\n                    10.1136\/jclinpath-2015-203089","journal-title":"J Clin Pathol"},{"issue":"7","key":"4036_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/jclinpath-2015-202944","volume":"68","author":"H Matsumoto","year":"2015","unstructured":"Matsumoto H, Koo SL, Dent R, Tan PH, Iqbal J (2015) Role of inflammatory infiltrates in triple negative breast cancer. J Clin Pathol 68(7):506\u2013510. doi:\n                    10.1136\/jclinpath-2015-202944","journal-title":"J Clin Pathol"},{"issue":"1","key":"4036_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13058-015-0632-x","volume":"17","author":"M Miyashita","year":"2015","unstructured":"Miyashita M, Sasano H, Tamaki K, Hirakawa H, Takahashi Y, Nakagawa S, Watanabe G, Tada H, Suzuki A, Ohuchi N, Ishida T (2015) Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study. Breast Cancer Res 17(1):124. doi:\n                    10.1186\/s13058-015-0632-x","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4036_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1586\/erm.10.97","volume":"11","author":"RA Mukhtar","year":"2011","unstructured":"Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ (2011) Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 11(1):91\u2013100. doi:\n                    10.1586\/erm.10.97","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"4036_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2013.1938","volume":"43","author":"E Obeid","year":"2013","unstructured":"Obeid E, Nanda R, Fu YX, Olopade OI (2013) The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol 43(1):5\u201312. doi:\n                    10.3892\/ijo.2013.1938","journal-title":"Int J Oncol"},{"issue":"4","key":"4036_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10555-010-9247-y","volume":"29","author":"MA Watanabe","year":"2010","unstructured":"Watanabe MA, Oda JM, Amarante MK, Cesar Voltarelli J (2010) Regulatory T cells and breast cancer: implications for immunopathogenesis. Cancer Metastasis Rev 29(4):569\u2013579. doi:\n                    10.1007\/s10555-010-9247-y","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"4036_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<200::AID-PATH726>3.0.CO;2-K","volume":"181","author":"AH Lee","year":"1997","unstructured":"Lee AH, Happerfield LC, Bobrow LG, Millis RR (1997) Angiogenesis and inflammation in ductal carcinoma in situ of the breast. J Pathol 181(2):200\u2013206. doi:\n                    10.1002\/(SICI)1096-9896(199702)181:2<200:AID-PATH726>3.0.CO;2-K","journal-title":"J Pathol"},{"issue":"1","key":"4036_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.1711610104","volume":"161","author":"S Ramachandra","year":"1990","unstructured":"Ramachandra S, Machin L, Ashley S, Monaghan P, Gusterson BA (1990) Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma\u2013a detailed morphological analysis. J Pathol 161(1):7\u201314. doi:\n                    10.1002\/path.1711610104","journal-title":"J Pathol"},{"issue":"2","key":"4036_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10549-013-2556-4","volume":"139","author":"A Lal","year":"2013","unstructured":"Lal A, Chan L, Devries S, Chin K, Scott GK, Benz CC, Chen YY, Waldman FM, Hwang ES (2013) FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast. Breast Cancer Res Treat 139(2):381\u2013390. doi:\n                    10.1007\/s10549-013-2556-4","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"4036_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-009-0654-0","volume":"123","author":"M Sharma","year":"2010","unstructured":"Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB (2010) Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Res Treat 123(2):397\u2013404. doi:\n                    10.1007\/s10549-009-0654-0","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"4036_CR34","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, Golland P, Sabatini DM (2006) Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7(10):R100. doi:\n                    10.1186\/gb-2006-7-10-r100","journal-title":"Genome Biol"},{"issue":"8","key":"4036_CR35","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/bioinformatics\/btr095","volume":"27","author":"L Kamentsky","year":"2011","unstructured":"Kamentsky L, Jones TR, Fraser A, Bray MA, Logan DJ, Madden KL, Ljosa V, Rueden C, Eliceiri KW, Carpenter AE (2011) Improved structure, function and compatibility for cell profiler: modular high-throughput image analysis software. Bioinformatics 27(8):1179\u20131180. doi:\n                    10.1093\/bioinformatics\/btr095","journal-title":"Bioinformatics"},{"issue":"3","key":"4036_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/modpathol.2015.158","volume":"29","author":"E Thompson","year":"2016","unstructured":"Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A, Emens LA (2016) The immune microenvironment of breast ductal carcinoma in situ. Mod Pathol 29(3):249\u2013258. doi:\n                    10.1038\/modpathol.2015.158","journal-title":"Mod Pathol"},{"issue":"10","key":"4036_CR37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","volume":"105","author":"LJ Solin","year":"2013","unstructured":"Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, Cherbavaz DB, Shak S, Page DL, Sledge GW Jr, Davidson NE, Ingle JN, Perez EA, Wood WC, Sparano JA, Badve S (2013) A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 105(10):701\u2013710. doi:\n                    10.1093\/jnci\/djt067","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"4036_CR38","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/modpathol.2015.79","volume":"28","author":"A Knopfelmacher","year":"2015","unstructured":"Knopfelmacher A, Fox J, Lo Y, Shapiro N, Fineberg S (2015) Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score. Mod Pathol 28(9):1167\u20131173. doi:\n                    10.1038\/modpathol.2015.79","journal-title":"Mod Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4036-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-4036-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4036-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:52:26Z","timestamp":1589719946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-4036-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["4036"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-4036-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,26]]},"assertion":[{"value":"19 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}